Antibiotic prophylaxis for spontaneous bacterial peritonitis: how and whom?

Review

P Ginès et al. J Hepatol. 1998 Sep.

. 1998 Sep;29(3):490-4.

doi: 10.1016/s0168-8278(98)80072-x.

No abstract available

Comment on

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.
Grangé JD, Roulot D, Pelletier G, Pariente EA, Denis J, Ink O, Blanc P, Richardet JP, Vinel JP, Delisle F, Fischer D, Flahault A, Amiot X. Grangé JD, et al. J Hepatol. 1998 Sep;29(3):430-6. doi: 10.1016/s0168-8278(98)80061-5. J Hepatol. 1998. PMID: 9764990 Clinical Trial.
Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages.
Terg R, Llano K, Cobas SM, Brotto C, Barrios A, Levi D, Wasen W, Bartellini MA. Terg R, et al. J Hepatol. 1998 Sep;29(3):437-42. doi: 10.1016/s0168-8278(98)80062-7. J Hepatol. 1998. PMID: 9764991 Clinical Trial.